-+ 0.00%
-+ 0.00%
-+ 0.00%

MANNKIND CORP - NO SERIOUS ADVERSE EVENTS OR DISCONTINUATIONS REPORTED IN PHASE 1B INFLO-1 STUDY

Reuters·07/29/2026 10:31:51

Please log in to view news